Literature DB >> 31073825

Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis.

Wei-Syun Hu1,2, Cheng-Li Lin3.   

Abstract

We investigated the adverse renal outcomes in patients affected by either atrial fibrillation (Afib) or atrial flutter (AFL). Using the Taiwan National Health Insurance research database, both cohorts were 1:1 propensity score matched based on age, sex, index year, and comorbidity using logistic regression model. Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) of acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease (ESRD) between the two cohorts were obtained using Cox proportional hazard regression models. Competing-risks regression models were applied to calculate the subhazard ratios (SHRs) and corresponding 95% CIs of the adverse renal outcomes. Afib patients were 1.15 and 1.33 times more likely to experience CKD and ESRD, respectively, than AFL patients (incidence rate per 10,000 person-years (IR): CKD, 10.8 vs 9.41; ESRD, 4.44 vs 3.34), with the adjusted HRs of 1.18 and 1.32 (CKD, 95% CI = 1.07-1.30; ESRD, 95% CI = 1.12-1.55). Afib patients were 1.08 times (95% CI = 1.01-1.16) more likely to have AKI than AFL patients after adjusting for confounding covariates. Competing risk analysis showed that Afib patients were 1.08 (95% CI = 1.01-1.15), 1.18 (95% CI = 1.07-1.30) and 1.32 (95% CI = 1.12-1.55) times more likely to experience AKI, CKD and ESRD than AFL subjects. This study showed that Afib conferred worse renal events of AKI, CKD and ESRD than AFL.

Entities:  

Keywords:  Acute kidney injury; Atrial fibrillation; Atrial flutter; Chronic kidney disease; End-stage renal disease

Mesh:

Year:  2019        PMID: 31073825     DOI: 10.1007/s11739-019-02089-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  3 in total

1.  Atrial fibrillation and kidney disease: insights on a close relationship.

Authors:  Giorgio Trivioli
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

2.  Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Authors:  Francesco Violi; Daniele Pastori
Journal:  Intern Emerg Med       Date:  2019-06-27       Impact factor: 3.397

3.  Construction of a Glycaemia-Based Signature for Predicting Acute Kidney Injury in Ischaemic Stroke Patients after Endovascular Treatment.

Authors:  Chengfang Liu; Xiaohui Li; Zhaohan Xu; Yishan Wang; Teng Jiang; Meng Wang; Qiwen Deng; Junshan Zhou
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.